الصفحة الرئيسية>>Signaling Pathways>> Neuroscience>> 5-HT Receptor>>Tertatolol ((±)-Tertatolol)

Tertatolol ((±)-Tertatolol) (Synonyms: (±)?-?Tertatolol; Racemic Tertatolol; dl-?Tertatolol)

رقم الكتالوجGC32637

Tertatolol ((± ؛) - Tertatolol) هو مضاد قوي لمستقبلات بيتا الأدرينالية ومستقبل 5-HT ، مع تأثيرات توسع الأوعية الكلوية الفريدة.

Products are for research use only. Not for human use. We do not sell to patients.

Tertatolol ((±)-Tertatolol) التركيب الكيميائي

Cas No.: 83688-84-0

الحجم السعر المخزون الكميّة
1mg
1176٫00
متوفر
5mg
2354٫00
متوفر
10mg
3998٫00
متوفر
20mg
7060٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tertatolol is a potent antagonist of beta-adrenoceptor and 5-HT receptor, with unique renal vasodilatatory effects.

In serum-free media, tertatolol does not significantly alter the incorporation of 3H-thymidine after 28 h of incubation in human mesangial cell (HMC). In the presence of 1% serum, tertatolol significantly reduces 3H-thymidine incorporation. Tertatolol also inhibits 3H incorporation when PDGF and thrombin are used as the stimulus. Tertatolol inhibits the reduction in planar surface area of HMC induced by angiotensin II. The inhibitory effect of tertatolol on HMC proliferation is also potentiated by ritanserin and MDL 72222, 5HT2 and 5HT3 antagonists, respectively[1].

[1]. Shultz P, et al. Tertatolol: a beta-blocker with unique effects on human glomerular cell function. Cardiology. 1993;83 Suppl 1:51-6.

مراجعات

Review for Tertatolol ((±)-Tertatolol)

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tertatolol ((±)-Tertatolol)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.